Absci ABSI
NASDAQ ABSI
$8.97 +0.17 (+1.93%)
As of: Sep 4, 2026 · 11:51 AM EDT

Absci (ABSI) Interest Expenses (2020 - 2026)

Absci (ABSI) posted Interest Expenses of $8.9 million for Q1 2026, up 30758.62% sequentially from $29000.0 in Q4 2025, and up 54.29% YoY from $5.8 million in Q1 2025.

Analysis

Absci (ABSI) Interest Expenses (2020 - 2026) Analysis & Trends

Absci has reported Interest Expenses for 7 years, with the latest figure at $8.9 million in Q1 2026.

  • Quarterly Interest Expenses rose 54.29% year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (up 54.29% YoY) and the FY2025 annual result came in at $106.2 million, up 36.16% from the prior year.
  • Interest Expenses improved to $8.9 million in Q1 2026 per ABSI's latest filing, from $29000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $55.4 million in Q1 2024 and troughed at $29000.0 in Q4 2025.
  • A 5-year average of $11.0 million and a median of $5.8 million in 2025 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2022 and 2023: Interest Expenses soared 9239.78% in 2022, then plunged 93.25% in 2023.
  • Over 5 years, Interest Expenses stood at $582000.0 in 2022, then sank by 71.82% to $164000.0 in 2023, then slumped by 33.54% to $109000.0 in 2024, then tumbled by 73.39% to $29000.0 in 2025, then jumped by 30758.62% to $8.9 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered $8.9 million, $29000.0, and $9.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn -1.00 Mn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - 23.78 Mn
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn - 93.62 Mn
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn 20.27 Mn
10 Absci 1.41 Bn 1.21 Bn - 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,000.00
Mar 31, 2026 18,000.00
Dec 31, 2025 29,000.00
Sep 30, 2025 45,000.00
Jun 30, 2025 56,000.00
Mar 31, 2025 79,000.00
Dec 31, 2024 109,000.00
Sep 30, 2024 130,000.00
Jun 30, 2024 150,000.00
Mar 31, 2024 176,000.00
Dec 31, 2023 204,000.00
Sep 30, 2023 229,000.00
Jun 30, 2023 256,000.00
Mar 31, 2023 321,000.00
Dec 31, 2022 287,000.00
Sep 30, 2022 279,000.00
Jun 30, 2022 211,000.00
Mar 31, 2022 195,000.00
Dec 31, 2021 200,000.00
Sep 30, 2021 768,000.00